ERAS Trial readout: Sunday, November 1, 2026
CompanyErasca, Inc. (ERAS)
EventTrial readout
DateSunday, November 1, 2026
MarketUS listing
SourceCT.gov registry · confidence 70% · primary source ↗
Est. Completion: 2026-11-01. Status: ACTIVE_NOT_RECRUITING. Title: A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.